|Company name||Regeneron Pharmaceuticals Inc|
|Live stock price||[stckqut]REGN[/stckqut]|
|P/E compared to competitors||Good|
|Confident Investor Rating||Good|
|Target stock price (TWCA growth scenario)||$392.29|
|Target stock price (averages with growth)||$298.11|
|Target stock price (averages with no growth)||$298.11|
|Target stock price (manual assumptions)||$378.92|
The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/regn
Regeneron Pharmaceuticals, Inc., incorporated on January 11, 1988, is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company’s marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for intravenous infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates. Its antibodies are generated using its VelocImmune technology.
Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Regeneron Pharmaceuticals Inc as long as the price is correct. Most of the fundamentals of Regeneron Pharmaceuticals Inc are good, in fact the company ranks as a Good company, but there are some concerns with the price of the stock and I am removing it from my Watch List.
If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.
How was this analysis of Regeneron Pharmaceuticals Inc calculated?
For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:
- Stock price at the time of the calculation: $320.26
- Growth: 0.14
- Current EPS (TTM): $21.13
- P/E: 15
- Future EPS Calc: $40.68
- Future Stock Price Calc: $610.26
- Target stock price: $378.92
I hope that this makes you a Confident Investor.